Five Prime Therapeutics, Inc. Deferred Offering Costs
Five Prime Therapeutics, Inc. had Deferred Offering Costs of $1.50 million as of 2013-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2014-08-07
- 2013-06-30: Deferred Offering Costs $1.50M.
| Period end | Deferred Offering Costs |
|---|---|
| 2013-06-30 | $1.50M 10-Q · filed 2014-08-07 |